Aurinia Pharmaceuticals Inc. (AUPH)

CIK 1600620 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Aurinia Pharmaceuticals Inc..

Recent SEC filings

FiledFormAccession number
Sep 11, 202640001600620-26-000068
Aug 26, 2026SCHEDULE 13D/A0001104659-26-101785
Aug 25, 202640001837798-26-000013
Aug 21, 20261440001837798-26-000010
Aug 19, 20268-K0001600620-26-000066
Aug 6, 202610-Q0001600620-26-000062
Aug 6, 20268-K0001600620-26-000059
Jun 8, 202640001896369-26-000002
Jun 8, 202640001500210-26-000002
Jun 8, 202640001302605-26-000002
Jun 8, 202640001370348-26-000002
Jun 5, 20261440001950047-26-005702
Jun 4, 20268-K0001600620-26-000053
Jun 4, 20261440001950047-26-005622
Jun 4, 2026SCHEDULE 13D/A0001214659-26-007175
Jun 2, 202640001178579-26-000004
Jun 2, 20261440001950047-26-005481
May 20, 202640001759910-26-000004
May 20, 202640001837798-26-000005
May 20, 202640002126966-26-000003
May 11, 20268-K0001140361-26-020402
May 11, 20261440001950047-26-004312
May 11, 2026SC TO-T/A0001140361-26-020397
May 11, 20261440001950047-26-004306
May 11, 20261440001950047-26-004310